![]() Praxbind (idarucizumab) is a humanized monoclonal antibody fragment (Fab) indicated in patients treated with Pradaxa® (dabigatran) when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures and in life-threatening or uncontrolled bleeding. Pradaxa ® (dabigatran etexilate mesylate) capsules is indicated: to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation for the treatment of deep. It is used to lower the chance of blood clots forming in your body by blocking thrombinthe blood's central clotting agent. You may report side effects to FDA at 1-80. PRADAXA is a type of anticoagulant(blood thinner) known as a direct thrombin inhibitor. RIDGEFIELD, Conn., Ma/PRNewswire/ - Today, Boehringer Ingelheim announced that Praxbind® (idarucizumab), a specific reversal agent for Pradaxa® (dabigatran etexilate mesylate), a novel oral anticoagulant (NOAC), is now stocked in more than 2,200 hospitals in all fifty states. Call your doctor for medical advice about side effects. Pradaxa® (dabigatran etexilate capsules) Savings Save on your Rx PATIENT SUPPORT FOR PEDIATRIC FORMULATION Call 1(833) 400-3472to speak with agent. ![]() ![]() Clinically, bivalirudin and argatroban are used as alternative. This is not a complete list of side effects and others may occur. Sign up for the Pradaxa® (dabigatran etexilate capsules) savings card and get valuable savings on your prescription. Argatroban and dabigatran bind to the active site on thrombin, inhibiting its activity. Learn about side effects, dosage, reversal of bleeds, and more. Treatment for: Reversal Agent for Pradaxa Common Pradaxa side effects may include: stomach pain or discomfort indigestion or. Pradaxa (dabigatran) is a brand-name drug used to decrease your risk of developing a blood clot. Last updated by Judith Stewart, BPharm on April 7, 2020.įDA Approved: Yes (First approved October 16, 2015)Ĭompany: Boehringer Ingelheim Pharmaceuticals, Inc.
0 Comments
Leave a Reply. |